About this item:

68 Views | 37 Downloads

Author Notes:

Craig Horbinski, MD, PhD, Scaife Hall, Suite A‐515, 200 Lothrop Street, Pittsburgh, PA 15213. Email: horbinskicm@upmc.edu

The authors wish to thank Cary Sipos, Kimberly Fuhrer and Christopher Simmons for their excellent histologic and immunohistochemical work, and Kathleen Cumbie for her technical support with the FISH analysis

Subject:

Research Funding:

Support for this work came from the Pathology Departments of the University of Pittsburgh and Duke University.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Clinical Neurology
  • Neurosciences
  • Pathology
  • Neurosciences & Neurology
  • array comparative genomic hybridization
  • chordoid glioma
  • fluorescence in situ hybridization
  • OF-THE-LITERATURE
  • CHROMOSOMAL IMBALANCES
  • 3RD-VENTRICLE
  • FEATURES
  • TUMORS
  • ENTITY
  • DIFFERENTIATION
  • EXPRESSION
  • ORIGIN
  • GENE

Chordoid Glioma: A Case Report and Molecular Characterization of Five Cases

Tools:

Journal Title:

BRAIN PATHOLOGY

Volume:

Volume 19, Number 3

Publisher:

, Pages 439-448

Type of Work:

Article | Final Publisher PDF

Abstract:

Chordoid gliomas are rare, slow-growing neoplasms of the anterior third ventricle. We reported a case of chordoid glioma in a 41-year-old man with obstructive hydrocephalus. Histologically, the tumor consisted of polygonal epithelioid cells admixed with elongated cells in a myxoid stroma. A prominent lymphoplasmacytic infiltrate was present. The tumor cells expressed glial fibrillary acidic protein (GFAP), epithelial membrane antigen (EMA), vimentin, CD31, CD34, epidermal growth factor receptor (EGFR) and S100 but were negative for pankeratin and E-cadherin. The percentage of Ki67 positive cells was approximately 3%. Weak p53 immunoreactivity was seen in less than 10% of the cells. Array comparative genomic hybridization performed on this case, as well as on four other archived cases, showed losses at several loci. Fluorescence in situ hybridization (FISH) confirmed consistent genetic alterations at 9p21 and 11q13. These are the fifth through ninth reported cases of chordoid gliomas with molecular characterization suggesting a distinct genetic origin from other gliomas. © 2008 International Society of Neuropathology.

Copyright information:

© 2008 The Authors; Journal Compilation © 2008 International Society of Neuropathology

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/rdf).
Export to EndNote